key: cord-0919048-jyh2fuh8
authors: Ushiro‐Lumb, Ines; Callaghan, Chris; Parmar, Jasvir; Olsburgh, Jonathon; Berman, Marius; Currie, Ian; Forsythe, John; Gardiner, Dale
title: Screening for SARS‐CoV‐2 in potential deceased organ donors
date: 2021-04-07
journal: Am J Transplant
DOI: 10.1111/ajt.16577
sha: 60c3e5ff9c04123a5be269488132e28f21faa4ca
doc_id: 919048
cord_uid: jyh2fuh8

We read with interest the case report by Kaul and colleagues detailing a proven case of transmission of SARS-CoV-2 from a lung donor with a negative nasopharyngeal swab (NPS) to a recipient in the United States (1). A surgeon who reported possible exposure to the patient's respiratory secretions, but none of the other staff involved, also became infected.

Regardless of previously negative results during the potential donor's hospital admission, a NPS and an endotracheal aspirate (ETA) are tested for SARS-CoV-2 RNA as part of the organ donor characterization. Both samples must test negative before proceeding to mobilization of organ recovery teams and must be obtained no longer than 24 hours before organ recovery. The rationale for an ETA as well as a NPS is to increase diagnostic sensitivity. 

Donor to recipient transmission of SARS-CoV-2 by lung transplantation despite negative donor upper respiratory tract testing

Multiorgan and renal tropism of SARS-CoV-2

A case of an infant with SARS-CoV-2 hepatitis early after liver transplantation

Organ and Tissue Donation and Transplantation, NHSBT. POL304 -SARS-CoV-2 assessment and screening in organ donors and recipients